| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	5-ASA
				
				
					Hyperhidrosis: postmarketing Sweating: postmarketing, 3% 5-azacytidine
				
				
					Sweating increased: 2.17% - 10.5% ACTH(1-39
				
				
					Sweating increased: postmarketing AMD3100
				
			Anidulafungin
				
			Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
				
				
					SweatingSweating increasedCAS 76095-16-4
				
				
					HyperhidrosisSweating increasedCAS 76420-72-9
				
				
					Sweating increased: postmarketing CGP 19835A
				
				
					Hyperhidrosis: very common, 11% Cancidas
				
				
					HyperhidrosisSweating: 0% - 3.4% Sweating increased: 2.2% - 2.8% Enfuvirtide
				
			FAMP
				
				
					Sweating increased: 1% - 13% FK463
				
			Fe(III
				
				
					Hyperhidrosis: postmarketing SweatingSweating increasedForteo
				
				
					Sweating: 2.2% Sweating increasedGd-DTPA
				
			Gd-EOB-DTPA
				
			Ge-132
				
			Glat copolymer
				
			Goserelin
				
				
					HyperhidrosisSweating: 4% - 45% Histrelin
				
			Humalog
				
				
					SweatingSweating increasedICI 182,780
				
			Insulin
				
				
					SweatingSweating increasedK779
				
				
					Sweating increased: 1% - 21% L-Dmp
				
				
					Sweating: 1% - 11.8% Sweating increased: postmarketing LY146032
				
				
					Sweating increased: 0% - 5% Leuprorelin
				
				
					Hyperhidrosis: postmarketing SweatingSweating increasedLisinopril
				
				
					SweatingSweating increased: very rare, postmarketing Lovaza
				
			Lutalyse
				
			MK-462
				
			Meropenem anhydrous
				
			Mersyndol
				
				
					SweatingSweating increasedMetrodin
				
			N-acetylcysteine
				
			N-carbamylglutamate
				
				
					HyperhidrosisSweating increasedNafarelin
				
			NovoLog
				
			Octreotide
				
			Optison
				
				
					Sweating increased: uncommon PGE1
				
			PGE2
				
			Protirelin
				
			Refludan
				
			Stalevo 50
				
			Supremon
				
			TlCl
				
			Triptorelin
				
			UDCA
				
			Vitrum
				
			Zyprexa Relprevv
				
			acamprosate
				
			acebutolol
				
			acetaminophen
				
				
					SweatingSweating increasedacetylcholine
				
			acitretin
				
				
					Sweating increased: postmarketing acyclovir
				
			adenosine
				
			agomelatine
				
			alfentanil
				
			alfuzosin
				
			allopurinol
				
				
					Sweating: postmarketing Sweating increasedalmotriptan
				
				
					Hyperhidrosis: postmarketing Sweating increased: infrequent alosetron
				
			alprazolam
				
				
					Sweating: 15.1% - 23.5% Sweating increased: frequent amantadine
				
				
					Sweating increased: postmarketing, uncommon, common amiodarone
				
			amisulpride
				
				
					Sweating increased: 0% - 1% amitriptyline
				
				
					Sweating increased: postmarketing amlodipine
				
			amlodipine besylate
				
			amphetamine
				
			amphotericin B
				
				
					Sweating: 7% - 10.8% Sweating increasedanagrelide
				
			anastrozole
				
				
					Sweating: 1% - 6.32% Sweating increasedanthracycline
				
				
					Sweating increased: 0% - 12% apomorphine
				
			aprepitant
				
				
					HyperhidrosisSweating increasedargenine vasopressin
				
			arginine
				
			aripiprazole
				
			arsenic
				
			arsenic trioxide
				
			aspirin
				
			atazanavir
				
			atenolol
				
			atomoxetine
				
				
					Hyperhidrosis: postmarketing, 4% Sweating increased: 4% atorvastatin
				
			atovaquone
				
			atropine
				
			azithromycin
				
			aztreonam
				
			baclofen
				
				
					Hyperhidrosis: uncommon, common SweatingSweating increased: uncommon benazepril
				
			benazeprilat
				
			bendamustine
				
			benzathine penicillin
				
			benzphetamine
				
			bepridil
				
			betaxolol
				
			bethanechol
				
			bexarotene
				
				
					Sweating: common, 0% - 6% bicalutamide
				
			bisoprolol
				
				
					SweatingSweating increased: 0.7% - 1% boceprevir
				
			bortezomib
				
			bosentan
				
			bretylium
				
			bromcresol green
				
				
					Sweating increased: 0% - 3% budesonide
				
				
					Sweating increased: 5.22% - 17.9% bumetanide
				
			bupivacaine
				
				
					HyperhidrosisSweating increasedSweating: postmarketing buprenorphine
				
				
					Hyperhidrosis: 4% Sweating: 12.6% - 14% bupropion
				
				
					HyperhidrosisSweating: postmarketing, frequent, 1.6% - 6% Sweating increased: 22.3% buspirone
				
			butorphanol
				
			cabergoline
				
				
					Sweating increased: 5.2% - 11.1% candesartan
				
			candesartan cilexetil
				
				
					SweatingSweating increasedcapecitabine
				
				
					HyperhidrosisSweating increased: 0.1% carbachol
				
				
					SweatingSweating increasedcarbamazepine
				
				
					Hyperhidrosis: very rare Sweating increased: very rare, rare carbidopa
				
			carbinoxamine
				
			carboprost
				
			carvedilol
				
			cefaclor
				
			cefditoren
				
			cefpodoxime
				
			ceftobiprole
				
			ceftriaxone
				
			cefuroxime
				
			celecoxib
				
			cetirizine
				
			cevimeline
				
				
					Sweating increased: 18.7% chloroprocaine
				
			chlorpheniramine
				
			cidofovir
				
			cilazapril
				
			ciprofloxacin
				
				
					Hyperhidrosis: rare Sweating: postmarketing, rare Sweating increasedcisplatin
				
			citalopram
				
				
					SweatingSweating increased: 3% - 11.3% Hyperhidrosiscladribine
				
				
					Hyperhidrosis: 3% Sweating increased: very common clarithromycin
				
				
					Hyperhidrosis: postmarketing clemastine
				
			clobazam
				
			clofarabine
				
			clomipramine
				
				
					HyperhidrosisSweating: very common Sweating increased: 9% - 29% clonidine
				
			clozapine
				
			codeine
				
				
					SweatingSweating increasedcopolymer 1
				
			cortisol
				
			cortisone
				
			cosyntropin
				
			cyclobenzaprine
				
			cyclophosphamide
				
				
					Hyperhidrosis: postmarketing Sweating: 0.1-1% Sweating increasedcyproheptadine
				
			cyproterone
				
			cyproterone acetate
				
				
					Sweating: common Sweating increasedcytarabine
				
				
					Sweating increased: 2.33% - 10.7% dabrafenib
				
			danazol
				
			dantrolene
				
			dapagliflozin
				
			darifenacin
				
			darunavir
				
			dasatinib
				
			deferiprone
				
				
					Hyperhidrosis: postmarketing degarelix
				
			delamanid
				
			delavirdine
				
			delta 9-THC
				
			demethyl
				
				
					HyperhidrosisSweating increaseddeprenyl
				
				
					Sweating: postmarketing, frequent Sweating increaseddesmopressin
				
			desonide
				
			desvenlafaxine
				
			dexamethasone
				
			dexamethasone sodium phosphate
				
			dexmedetomidine
				
				
					Sweating increased: postmarketing dextrorphan
				
			diatrizoate
				
			diazepam
				
			diazoxide
				
			diclofenac
				
				
					SweatingSweating increaseddiethylpropion
				
			diflunisal
				
			dihydrocodeine
				
			dihydroergotamine
				
				
					Sweating increased: postmarketing, infrequent diltiazem
				
			dimercaprol
				
			diphenhydramine
				
			dipyridamole
				
			disopyramide
				
			dofetilide
				
			dolasetron
				
			donepezil
				
				
					Sweating: infrequent Sweating increased: frequent dorzolamide
				
			dothiepin
				
			doxapram
				
			doxazosin
				
				
					SweatingSweating increased: 1% - 1.4% doxepin
				
				
					Hyperhidrosis: rare Sweatingdoxorubicin
				
			duloxetine
				
				
					Hyperhidrosis: 2% - 10% Sweating increasededrophonium
				
			efavirenz
				
				
					SweatingSweating increased: 0% - 2% eletriptan
				
			entacapone
				
				
					SweatingSweating increased: common, 2% - 3.6% ephedrine
				
			epinephrine
				
				
					SweatingSweating increasedeplerenone
				
			eprosartan
				
			ergonovine
				
			eribulin
				
			ertapenem
				
			eslicarbazepine acetate
				
			esmolol
				
				
					HyperhidrosisSweating increased: 9% esomeprazole magnesium
				
				
					Hyperhidrosis: postmarketing Sweating increasedestazolam
				
			estradiol
				
				
					Hyperhidrosis: postmarketing Sweating increasedetodolac
				
			etoposide
				
			etoposide phosphate
				
			etravirine
				
			everolimus
				
			exemestane
				
				
					Sweating: 6-19% Sweating increased: common, very common, 4.5% - 17.8% exenatide
				
			famciclovir
				
			febuxostat
				
			felbamate
				
			fenofibrate
				
			fenoldopam
				
			fenoprofen
				
			fentanyl
				
				
					Hyperhidrosis: 0% - 14.3% Sweating: 0% - 4% Sweating increased: very rare, postmarketing ferumoxytol
				
				
					Hyperhidrosis: postmarketing Sweating: postmarketing flecainide
				
			fluconazole
				
				
					Sweating increased: postmarketing fludarabine
				
				
					Sweating increased: 0% - 14% fludrocortisone
				
			fludrocortisone acetate
				
			flumazenil
				
				
					SweatingSweating increasedflunisolide
				
			flunitrazepam
				
			fluorescein
				
				
					Hyperhidrosis: postmarketing fluoxetine
				
				
					Sweating: common, 2% - 8.9% Sweating increasedfluphenazine decanoate
				
			flurazepam
				
			flurbiprofen
				
			fluvastatin
				
			fluvoxamine
				
				
					HyperhidrosisSweating: common, 1% - 7% Sweating increased: frequent, 6.9% - 11.2% fosaprepitant
				
			fosaprepitant dimeglumine
				
			foscarnet
				
			fosinopril
				
				
					Hyperhidrosis: uncommon Sweating increasedfosinoprilat
				
				
					HyperhidrosisSweating increasedfosphenytoin
				
			frovatriptan
				
				
					Sweating increased: frequent furosemide
				
			gabapentin
				
				
					Sweating: postmarketing, infrequent Sweating increased: infrequent gadobenate dimeglumine
				
			gadobutrol
				
			gadodiamide
				
			gadofosveset
				
			gadolinium
				
				
					Hyperhidrosis: postmarketing, 0.9% Sweating increasedgadopentetate
				
			gadoteridol
				
			gadoversetamide
				
				
					HyperhidrosisSweating increasedgalantamine
				
			ganciclovir
				
			gatifloxacin
				
			gemcitabine
				
			gemifloxacin
				
			glibenclamide
				
			gliclazide
				
			glimepiride
				
				
					SweatingSweating increasedglipizide
				
			glutamine
				
				
					Sweating increased: 0% - 12.5% glycopyrrolate
				
			gold sodium thiomalate
				
			granisetron
				
			guanfacine
				
			guanidinium
				
			haloperidol
				
				
					Hyperhidrosis: very rare, postmarketing Sweating increasedhepatitis B vaccines
				
			histamine
				
			hydrochlorothiazide
				
			hydrocodone
				
			hydromorphone
				
				
					Hyperhidrosis: 1.49% - 5.78% SweatingSweating increasedhydroxybutyrate
				
				
					Hyperhidrosis: 1% - 3% Sweating increased: 0% ibandronate
				
			ibuprofen
				
			ifosfamide
				
				
					Hyperhidrosis: postmarketing imatinib
				
				
					Sweating: 2.8% - 12.7% Sweating increased: uncommon, 0.2% - 14.8% imipramine
				
				
					Hyperhidrosis: very common imiquimod
				
				
					Sweating increased: uncommon, 0.1% indapamide
				
			indinavir
				
			indomethacin
				
				
					Hyperhidrosis: 0% - 2% Sweatinginsulin detemir
				
				
					HyperhidrosisSweatingSweating increasediodixanol
				
			iopamidol
				
				
					SweatingSweating increasediopromide
				
				
					Hyperhidrosis: postmarketing SweatingSweating increasediotrolan
				
			ioxaglate
				
			ioxilan
				
			ipratropium bromide
				
			irbesartan
				
			irbesartan-hydrochlorothiazide
				
			irinotecan
				
				
					Sweating: 0% - 57% Sweating increasedisocarboxazid
				
			isomannide
				
				
					SweatingSweating increasedisoproterenol
				
			isosorbide-5-mononitrate
				
				
					SweatingSweating increasedisradipine
				
			itraconazole
				
				
					HyperhidrosisSweating increased: 0% - 6% ivermectin
				
			ketoprofen
				
			ketorolac
				
			ketorolac tromethamine
				
				
					Sweating: postmarketing Sweating increasedlabetalol
				
				
					SweatingSweating increased: 0% - 1% lacosamide
				
			lamivudine
				
				
					Sweating: 1% - 7.6% Sweating increased: 5% lamotrigine
				
				
					Sweating: infrequent, 0% - 2% lanreotide
				
			lansoprazole
				
			lasofoxifene
				
			leflunomide
				
			lenalidomide
				
				
					Hyperhidrosis: postmarketing SweatingSweating increased: common, 9.92% lercanidipine
				
				
					Sweating increased: uncommon letrozole
				
				
					Sweating: 1-22% Sweating increased: common, 0.039% - 24.2% leuprorelin acetate
				
				
					Sweating: 8.33% - 82.5% Sweating increased: 12.7% - 79.9% levodopa/carbidopa
				
			levonorgestrel
				
			lidocaine
				
			linezolid
				
			lisdexamfetamine dimesylate
				
			lisuride
				
			lomefloxacin
				
			lomitapide
				
			lorcaserin
				
			lormetazepam
				
			losartan
				
			lubiprostone
				
			lurasidone
				
			magnesium
				
			maprotiline
				
				
					HyperhidrosisSweating increasedmedroxyprogesterone
				
				
					Sweating increased: postmarketing medroxyprogesterone acetate
				
				
					SweatingSweating increasedmefloquine
				
				
					Hyperhidrosis: postmarketing Sweating: postmarketing megestrol
				
			megestrol acetate
				
			meloxicam
				
				
					Hyperhidrosis: 0% - 1.3% SweatingSweating increasedmemantine
				
			meperidine
				
			mepivacaine
				
				
					SweatingSweating increasedmeropenem
				
			mesna
				
				
					HyperhidrosisSweating increased: 1.7% - 9% metaproterenol
				
				
					SweatingSweating increased: 0.2% - 1% metformin
				
			methadone
				
				
					SweatingSweating increasedmethotrexate
				
			methylene blue
				
				
					HyperhidrosisSweatingSweating increasedmethylergometrine
				
			methylnaltrexone
				
			methylphenidate
				
				
					Hyperhidrosis: common, 5.1% - 5.7% Sweatingmethylprednisolone
				
				
					HyperhidrosisSweatingSweating increasedmethylprednisolone sodium succinate
				
			metoprolol
				
				
					Hyperhidrosis: very rare Sweating: postmarketing Sweating increased: very rare, postmarketing, uncommon metronidazole
				
			mexiletine
				
			milnacipran
				
			mirtazapine
				
				
					Sweating: postmarketing Sweating increased: postmarketing misoprostol
				
				
					Sweating increased: postmarketing mitoxantrone
				
				
					SweatingSweating increased: 9% moclobemide
				
			modafinil
				
				
					Hyperhidrosis: postmarketing, 1% Sweatingmoexiprilat
				
			morphine
				
				
					SweatingHyperhidrosisSweating increased: 2% moxifloxacin
				
			mycophenolate mofetil
				
			mycophenolic acid
				
			nabilone
				
			nabumetone
				
			nadolol
				
			nalbuphine
				
			nalmefene
				
			naloxone
				
			naltrexone
				
				
					Sweating increased: postmarketing naphazoline
				
			naproxen
				
			naratriptan
				
			nateglinide
				
				
					SweatingSweating increasednefazodone
				
			nefopam
				
			nelfinavir
				
			neostigmine
				
				
					Sweating increased: postmarketing nesiritide
				
			niacin
				
			nicardipine
				
				
					Sweating: 1.4% Sweating increased: 0.6% nicorandil
				
			nicotine
				
			nifedipine
				
				
					SweatingSweating increasednilotinib
				
			nilutamide
				
			nimodipine
				
			nisoldipine
				
			nitrazepam
				
			nitrite
				
			nitroglycerin
				
				
					SweatingSweating increasednitroprusside
				
			nizatidine
				
			norepinephrine
				
			norfloxacin
				
			nortriptyline
				
				
					SweatingSweating increasedofatumumab
				
			ofloxacin
				
			olanzapine
				
				
					Sweating: postmarketing, infrequent, frequent Sweating increased: postmarketing olmesartan
				
				
					Hyperhidrosis: 0% - 3.45% omeprazole
				
				
					Hyperhidrosis: postmarketing Sweating increased: rare, uncommon orlistat
				
				
					Sweating increased: uncommon ospemifene
				
			oxaliplatin
				
				
					SweatingSweating increased: 0% - 8% oxaprozin
				
			oxcarbazepine
				
			oxprenolol
				
			oxycodone
				
				
					HyperhidrosisSweating: 5% - 6% oxymorphone
				
				
					Sweating increased: 8.6% - 9% paclitaxel
				
				
					HyperhidrosisSweating increasedpamidronate
				
			pantoprazole
				
				
					SweatingSweating increasedparaldehyde
				
			parecoxib
				
			paricalcitol
				
			paroxetine
				
				
					Hyperhidrosis: postmarketing Sweating: postmarketing, uncommon, common, 0% - 14% Sweating increased: very rare, postmarketing pazopanib
				
			penbutolol
				
			penicillin
				
			pentazocine
				
				
					SweatingSweating increasedpentosan polysulfate
				
				
					SweatingSweating increased: 1% pentostatin
				
				
					Sweating: 8% - 21% Sweating increased: 8% - 21% pentoxifylline
				
			pergolide
				
			perhexiline
				
			perindopril
				
			perindopril erbumine
				
			phendimetrazine
				
			phenelzine
				
			phenylephrine
				
			phenytoin
				
			pilocarpine
				
			pimozide
				
				
					Hyperhidrosis: postmarketing Sweatingpindolol
				
			pioglitazone
				
			piperacillin
				
			piroxicam
				
			pomalidomide
				
				
					Hyperhidrosis: 5.61% - 16.1% ponatinib
				
			posaconazole
				
				
					Sweating increased: 1.91% - 9.62% pramipexole
				
				
					Hyperhidrosis: 1.6% Sweatingpravastatin
				
			prazosin
				
			prednisolone
				
			prednisolone acetate
				
			prednisolone phosphate
				
			prednisone
				
			pregabalin
				
				
					HyperhidrosisSweating: infrequent prilocaine
				
			procaine
				
			procarbazine
				
				
					SweatingSweating increasedprogesterone
				
			propafenone
				
				
					Sweating increased: 0.3% - 1.4% propericiazine
				
			propofol
				
			prostacyclin
				
			pyridostigmine
				
			quetiapine
				
				
					Hyperhidrosis: 2% Sweating: frequent, 2% quinapril
				
			quinaprilat
				
			quinidine
				
			rabeprazole
				
			raloxifene
				
			raltegravir
				
			raltitrexed
				
			ramipril
				
				
					SweatingSweating increasedramiprilat
				
			ranitidine
				
			ranolazine
				
			rapamycin
				
			rasagiline
				
			reboxetine
				
				
					Hyperhidrosis: 12.1% Sweatingregadenoson
				
			remifentanil
				
			retigabine
				
			retinoic acid
				
				
					Sweating: postmarketing Sweating increased: 20% ribavirin
				
				
					Hyperhidrosis: common Sweating increased: common, 5% - 41% rifapentine
				
			rifaximin
				
			riluzole
				
			rimantadine
				
			rimonabant
				
			risperidone
				
				
					SweatingSweating increased: infrequent ritonavir
				
			rivastigmine
				
				
					Hyperhidrosis: uncommon, common, 2% Sweating: uncommon Sweating increased: common, frequent, 2% - 4% rizatriptan
				
			ropinirole
				
				
					Hyperhidrosis: 3% Sweating increased: 1.4% - 7% ropivacaine
				
				
					Sweating increased: 0.4% - 1.3% rotigotine
				
				
					Hyperhidrosis: 1% - 3% Sweating increasedsalbutamol
				
				
					Sweating: 1% Sweating increasedsalmon calcitonin acetate
				
				
					Sweating increased: postmarketing samarium
				
			saquinavir
				
			scopolamine
				
			sertraline
				
				
					SweatingSweating increased: postmarketing, common, 3% - 11% sibutramine
				
			sildenafil
				
			sodium
				
			sodium ferric gluconate
				
			sodium iothalamate
				
			sodium nitroprusside
				
			sotalol
				
				
					Hyperhidrosis: 4.9% - 5.2% sparfloxacin
				
			stavudine
				
			sulindac
				
				
					SweatingSweating increasedsumatriptan
				
				
					Sweating: rare, frequent, 0.6% - 2% tacrolimus
				
				
					SweatingSweating increased: common Hyperhidrosistadalafil
				
				
					Hyperhidrosis: postmarketing Sweating: postmarketing tamoxifen
				
			tamsulosin
				
			tapentadol
				
			tegaserod
				
			telavancin
				
			telithromycin
				
			telmisartan
				
				
					Hyperhidrosis: rare, uncommon Sweating increased: postmarketing, uncommon temazepam
				
			temozolomide
				
				
					Sweating increased: uncommon teniposide
				
			tenofovir
				
			tenofovir disoproxil fumarate
				
			terazosin
				
			terbutaline
				
			testosterone
				
				
					Hyperhidrosis: postmarketing, 1.31% Sweating: postmarketing Sweating increasedtestosterone undecanoate
				
			tetrabenazine
				
			thalidomide
				
			thiamine
				
			thioridazine
				
				
					Sweating increased: postmarketing thiothixene
				
			thyroxine
				
				
					SweatingSweating increasedtiagabine
				
			tiaprofenic acid
				
			tigecycline
				
			timolol
				
			tinidazole
				
			tirofiban
				
			tizanidine
				
			tolcapone
				
				
					SweatingSweating increased: 4% topiramate
				
				
					Sweating increased: 1% - 2% topotecan
				
			toremifene
				
				
					Sweating: postmarketing, 17% - 20% tramadol
				
				
					Sweating: common, 4.2% - 9% Sweating increased: postmarketing, 0.463% - 7.44% trametinib
				
			trandolapril
				
				
					HyperhidrosisSweating: postmarketing trandolaprilat
				
			tranylcypromine
				
			trazodone
				
				
					Hyperhidrosis: infrequent Sweating: 1.4% triamcinolone
				
			triamcinolone acetonide
				
			triazolam
				
			tropicamide
				
			trospium chloride
				
			trovafloxacin
				
			v 1784
				
				
					Sweating increased: postmarketing valdecoxib
				
			valganciclovir
				
			valproate
				
				
					SweatingSweating increasedvardenafil
				
			varenicline
				
				
					Hyperhidrosis: uncommon, frequent vasopressin
				
			venlafaxine
				
				
					Sweating: postmarketing, common, 1% - 19.3% verapamil
				
				
					Sweating: postmarketing Sweating increasedvernakalant
				
			verteporfin
				
			vilazodone
				
			vildagliptin
				
			vincristine
				
			vinflunine
				
			vitamin K
				
				
					SweatingSweating increasedvoriconazole
				
			zalcitabine
				
			zaleplon
				
			ziconotide
				
			zidovudine
				
				
					Sweating: rare Sweating increased: 5% zidovudine/lamivudine
				
				
					Sweating: 6.3% - 7.6% Sweating increasedziprasidone
				
				
					Sweating: 0% - 2% Sweating increasedzoledronic acid
				
				
					Hyperhidrosis: common, 2% - 2.6% Sweating increased: postmarketing, uncommon zolmitriptan
				
				
					Sweating: infrequent, 0% - 3% zolpidem
				
				
					Hyperhidrosis: postmarketing, rare Sweating increased: infrequent zonisamide
				
			zopiclone
				
			zuclopenthixol
				
				
					HyperhidrosisSweatingSweating increased | Drugs with this indication |